DUPIXENT is now approved for your adult patients with uncontrolled moderate-to-severe atopic dermatitis.
DUPIXENT is indicated for the treatment of adult patients with
moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
DUPIXENT can be used with or without topical corticosteroids.
Request a Field Representative Visit
The DUPIXENT MyWayTM program offers your patients support in navigating reimbursement, help with covering the cost of DUPIXENT and educational services.